title: The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis.
abstract: The aim of this study was to analyze the donor risk factors associated with second orthotopic liver transplantation (reOLT) and graft loss after OLT within 1 month. A total of 649 OLTs performed in 11 centers in Spain during the period from 1992 to 1993 were analyzed retrospectively. Eleven donor and recipient variables were studied. Biochemical evolution of the OLT, biliary and arterial complications, patient status (alive, retransplanted, or dead), and follow-up were also recorded. Bivariate study demonstrated that extended preservation ( > 12 hr) was associated with increased biliary complications (P = 0.02), and lower prothrombin time (P = 0.04). In a logistic model regression for biliary complications, ischemia > 12 hr was an independent risk factor (odds ratio = 2.2, 95% confidence interval [CI] = 1.1-4.3). The multivariate Cox proportional model of potential risk factors showed that only urgent reOLT (relative risk [RR] = 2.7, 95% CI = 1.4-5.4) was independently associated with higher 30-day mortality. Donor plasma sodium > 155 mmol/L (RR = 1.4, 95% CI = 1.0-2.2) and incompatible ABO graft (RR = 3.2, 95% CI = 1.3-7.9) were independently associated with increased rate of reOLT before 30 days. Donor plasma sodium > 155 mmol/L (RR = 2, 95% CI = 1.1-3.6) and incompatible graft (RR = 3.3, 95% CI = 1.4-8.2) were independently associated with graft loss (death or reOLT) before 1 month. We conclude that cold ischemia should be kept less than 12 hr in order to avoid biliary complications. Donors over 60 years old or with plasma sodium > 155 should be carefully evaluated before OLT.
authors.affiliation: Grupos de Transplante Hepático, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Figueras
authors.forename: J
authors.initials: J
authors.lastname: Busquets
authors.forename: L
authors.initials: L
authors.lastname: Grande
authors.forename: E
authors.initials: E
authors.lastname: Jaurrieta
authors.forename: J
authors.initials: J
authors.lastname: Perez-Ferreiroa
authors.forename: J
authors.initials: J
authors.lastname: Mir
authors.forename: C
authors.initials: C
authors.lastname: Margarit
authors.forename: P
authors.initials: P
authors.lastname: Lopez
authors.forename: J
authors.initials: J
authors.lastname: Vazquez
authors.forename: D
authors.initials: D
authors.lastname: Casanova
authors.forename: A
authors.initials: A
authors.lastname: Bernardos
authors.forename: E
authors.initials: E
authors.lastname: De-Vicente
authors.forename: P
authors.initials: P
authors.lastname: Parrilla
authors.forename: J M
authors.initials: JM
authors.lastname: Ramon
authors.forename: R
authors.initials: R
authors.lastname: Bou
mesh_terms: D000293:Adolescent; D000328:Adult; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects; D008875:Middle Aged; D015999:Multivariate Analysis; D009926:Organ Preservation / Q000009:adverse effects / Q000379:methods*; D011379:Prognosis; D012086:Reoperation; D012307:Risk Factors; D012964:Sodium / Q000097:blood*; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D012964:Sodium